Intratumoural administration and tumour tissue targeting of cancer immunotherapies
Ignacio Melero(Universidad de Navarra), Aurélien Marabelle(Université Paris-Saclay)
Cited by 469
Related Papers
Cytokines in clinical cancer immunotherapy
|British Journal of Cancer|2018|1.2k
CXCR1 and CXCR2 Chemokine Receptor Agonists Produced by Tumors Induce Neutrophil Extracellular Traps that Interfere with Immune Cytotoxicity
|Immunity|2020|749
Immunostimulatory monoclonal antibodies for cancer therapy
|Nature reviews. Cancer|2007|628
OX40 Agonist BMS-986178 Alone or in Combination With Nivolumab and/or Ipilimumab in Patients With Advanced Solid Tumors
|Clinical Cancer Research|2020|109
Cellular cytotoxicity is a form of immunogenic cell death
|Journal for ImmunoTherapy of Cancer|2020|93